NanoViricides prices US$2 million registered direct offering with warrants

NanoViricides, Inc.

NanoViricides, Inc.

NNVC

0.00
  • NanoViricides entered securities purchase agreement with single institutional investor for registered direct offering expected to raise about US$2 million in gross proceeds.
  • Deal covers 1,333,334 common shares, or pre-funded warrants in lieu of shares, issued with accompanying warrants for 1,333,334 shares.
  • Warrants carry exercise price of US$1.75 per share, expire three years from issuance.
  • Closing expected on or about May 18, 2026, subject to customary conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202605150835ACCESSWRNAPR_____1167342) on May 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.